Blue Biofuels (BIOF) 10-Q/A 20 May 24 2024 Q1 Quarterly report (amended) Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2024	May 18, 2024
Cover [Abstract]
Document Type	10-Q/A
Amendment Flag	true
Amendment Description	This Amendment No. 1 on Form 10-Q/A (the “Amendment”) amends the Quarterly Report on Form 10-Q of Blue Biofuels, Inc. (the “Company”) for the fiscal quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on May 6th, 2024 (the “Original Filing”). This Amendment is being filed because the Original Filing was reviewed by BF Borgers and its sole partner Ben Borgers who were suspended from practicing before the Commission which prevented the prior report from being included in the Company’s filings with the Commission. Various changes were made to the Quarterly Report by the Company after being reviewed by its new audit firm, Assure CPA, including changes to the condensed consolidated balance sheet and statement of operations.
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	000-54942
Entity Registrant Name	BLUE BIOFUELS, INC.
Entity Central Index Key	0001549145
Entity Tax Identification Number	45-4944960
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	3710 Buckeye Street
Entity Address, Address Line Two	Suite 120
Entity Address, City or Town	Palm Beach Gardens
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33410
City Area Code	(888)
Local Phone Number	607-3555
Title of 12(b) Security	Common Stock par value $0.001
Trading Symbol	BIOF
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		302,865,508

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 24,319	$ 41,008
Prepaid expenses	32,751	35,750
TOTAL CURRENT ASSETS	57,070	76,758
Other assets
Property and equipment, net of accumulated depreciation and amortization of $272,899 and $243,089 at March 31, 2024 and December 31,2023, respectively	557,498	587,308
Security deposits	30,276	30,276
Right of Use Assets, net of accumulated amortization	56,764	81,091
Patents	275,611	254,786
TOTAL OTHER ASSETS	920,149	953,461
TOTAL ASSETS	977,219	1,030,219
Current liabilities
Right of Use Lease Liability - Current	60,637	85,983
Interest Payable - Related Party	185,498	143,406
TOTAL CURRENT LIABILITIES	2,068,099	1,503,169
Long term liabilities
Legacy Notes Payable — Other	216,570	216,570
TOTAL LONG TERM LIABILITIES	3,128,132	3,088,132
TOTAL LIABILITIES	5,196,231	4,591,301
COMMITMENTS AND CONTINGENCIES (Note 8)
STOCKHOLDERS’ DEFICIT
Preferred stock; $0.001 par value; 10,000,000 shares authorized; zero shares issued and outstanding
Common stock; $0.001 par value; 1,000,000,000 shares authorized; 302,803,463 issued and outstanding at March 31, 2024, and 302,750,963 shares issued and outstanding at December 31, 2023.	302,803	302,751
Additional paid-in capital	52,261,837	51,972,947
Accumulated deficit	(56,783,652)	(55,836,780)
TOTAL STOCKHOLDERS’ DEFICIT	(4,219,012)	(3,561,082)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	977,219	1,030,219
Nonrelated Party [Member]
Current liabilities
Accounts payable	25,282	22,798
Convertible Notes Payable	200,000
Long term liabilities
Convertible Notes Payable – Other	50,000	50,000
Related Party [Member]
Current liabilities
Accounts payable	72,670	72,670
Deferred wages and directors fees - Related party	1,154,012	828,312
Convertible Notes Payable	370,000	350,000
Long term liabilities
Convertible Notes Payable – Other	340,000	300,000
Legacy Notes Payable — Related Party	$ 2,521,562	$ 2,521,562

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Property and equipment, net of accumulated depreciation and amortization	$ 272,899	$ 243,089
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	302,803,463	302,750,963
Common stock, shares outstanding	302,803,463	302,750,963

Condensed Consolidated Statemen

Condensed Consolidated Statement of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Related Party Transaction [Line Items]
Revenues
Operating expense:
General and administrative	295,982	369,845
Research & Development	607,635	684,562
Loss on disposal of assets		369
Total operating expenses	903,617	1,054,776
Loss from operations:	(903,617)	(1,054,776)
Other (income) expense:
Interest expense - other	1,163	2,602
Total other (income) expense	43,255	9,314
Income (Loss) before provisions for income taxes	(946,872)	(1,064,090)
Provisions for income taxes
Net Income / (Loss):	$ (946,872)	$ (1,064,090)
Net income (loss) per share - Basic	$ (0.003)	$ (0.004)
Net income (loss) per share - Diluted	$ (0.003)	$ (0.004)
Weighted average common shares outstanding
Basic	302,788,463	295,025,276
Diluted	302,788,463	295,025,276
Related Party [Member]
Other (income) expense:
Interest expense - related party	$ 42,092	$ 6,712

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022	$ 289,942	$ 50,134,727	$ (52,781,586)	$ (2,356,917)
Balance, shares at Dec. 31, 2022	289,941,623
Issuance of common stock for services	$ 140	23,860		24,000
Issuance of common stock for services, shares	140,000
Issuance of common stock and warrants for cash through PPM	$ 3,885	578,865		582,750
Issuance of common stock and warrants for cash through PPM, shares	3,884,998
Warrants exercised	$ 5,450	66,800		72,250
Warrants exercised, shares	5,450,148
Vesting of options and adjustment of strike prices under the employee, director plan		391,297		391,297
Net Income (Loss)			(1,064,090)	(1,064,090)
Balance at Mar. 31, 2023	$ 299,417	51,195,549	(53,845,676)	(2,350,710)
Balance, shares at Mar. 31, 2023	299,416,769
Balance at Dec. 31, 2023	$ 302,751	51,972,947	(55,836,780)	(3,561,082)
Balance, shares at Dec. 31, 2023	302,750,963
Issuance of common stock for services	$ 52	4,148		$ 4,200
Issuance of common stock for services, shares	52,500			52,500
Issuance of common stock and warrants for cash through PPM, shares				0
Vesting of options and adjustment of strike prices under the employee, director plan		279,248		$ 279,248
Net Income (Loss)			(946,872)	(946,872)
Issuance of warrants for services		5,494		5,494
Balance at Mar. 31, 2024	$ 302,803	$ 52,261,837	$ (56,783,652)	$ (4,219,012)
Balance, shares at Mar. 31, 2024	302,803,463

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) (Parenthetical) - shares		3 Months Ended
	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]
Vesting of options previously issued under employee director plan	29,955,000	1,875,000	2,385,000
Warrants issued for services		87,500

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net Income (Loss)	$ (946,872)	$ (1,064,090)
Reconciliation of net loss to net cash used in operating activities
Depreciation and amortization	29,810	29,842
Stock based compensation or services	288,942	415,297
Loss on Disposal of assets		369
Changes in operating assets and liabilities
Prepaid expenses	2,999	(18,000)
Accrued interest - related party	42,092	6,712
Accounts payable and accrued liabilities	328,184	19,559
Right of use lease	(1,019)	1,192
Net cash used in operating activities	(255,864)	(609,119)
Cash flows from investing activities
Net Purchase of property and equipment		(282,038)
Patent Costs	(20,825)	(12,621)
Net cash used in investing activities	(20,825)	(294,659)
Cash flows from financing activities
Proceeds from exercise of warrants and options		72,250
Chapter 11 Settlement		(50,000)
Net Proceeds from the issuance of Convertible Notes	260,000	250,000
Net proceeds from issuance of common stock		582,750
Net cash provided by financing activities	260,000	855,000
Net decrease in cash and cash equivalents	(16,689)	(48,778)
Cash and cash equivalent at beginning of the period	41,008	211,901
Cash and cash equivalent at end of the period	$ 24,319	$ 163,123

ORGANIZATION

ORGANIZATION	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	NOTE 1 – ORGANIZATION Blue Biofuels, Inc., was incorporated in Nevada on March 28, 2012, as Alliance Media Group Holdings, Inc. Since December 2013, Blue Biofuels, Inc. (the “Company”) has been a technology company focused on emerging technologies in renewable energy, biofuels, and lignin.

GOING CONCERN

GOING CONCERN	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern, which assumes the Company will realize its assets and discharge its liabilities in the normal course of business. The Company has not generated any significant revenue since inception and has incurred losses since inception. As of March 31, 2024, the Company has incurred accumulated losses of $ 56,783,652 Management believes that the Company’s future success is dependent upon its ability to achieve profitable operations, generate cash from operating activities, and obtain additional financing. There is no assurance that the Company will be able to generate sufficient cash from operations, or sell additional shares of stock or borrow additional funds. The Company’s inability to obtain additional cash could have a material adverse effect on its financial position, results of operations, and its ability to continue in existence. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The condensed consolidated financial statements are prepared in accordance with Operating results for the three months ended March 31, 2024, may not be indicative of full year 2024 results. In management’s opinion, the accompanying condensed consolidated financial statements contain all adjustments necessary for a fair statement of our financial position as of March 31, 2024, and our results of operations, changes in stockholders’ deficit and cash flows for the three months ended March 31, 2024 and 2023. Stock Compensation The Company recognizes the cost of all share-based payments under the relevant authoritative accounting guidance. Share-based payments include any remuneration paid by the Company in shares of the Company’s common stock or financial instruments that grant the recipient the right to acquire shares of the Company’s common stock. For share-based payments to employees, which consist only of awards made under the stock option plan described below, the Company accounts for the payments in accordance with the provisions of ASC Topic 718, “Stock Compensation”. Share-based payments to consultants, service providers and other non-employees are accounted for in accordance with ASC Topic 718, or other applicable authoritative guidance. Stock-based Compensation Valuation Methodology Stock-based compensation resulting from the issuance of common stock is calculated by reference to the valuation of the stock on the date of issuance, the expense being recognized as the compensation is earned. Stock-based compensation expenses related to employee options and warrants granted to non-employees are recognized as the stock options and warrants are earned. The fair value of the stock options or warrants granted is estimated at the grant date, using the Black-Scholes option-pricing model, and the expense is recognized on a straight-line basis over the shorter of the period over which services are to be received or the life of the option or warrant. The grant date fair value of employee share options and similar instruments is estimated using the Black-Scholes option-pricing model on the basis of the fair value of the underlying common stock on the measurement date, adjusted for the unique characteristics of those equity instruments, using the assumptions noted in the table below. The fair value of the common stock is determined by the then-prevailing closing market price. Expected volatility was based on the historical volatility of the Company’s closing day market price per share. The expected term of options and warrants was based upon the life of the option, and the risk-free rate used was based on the U.S. Treasury Daily Yield Curve Rate. The stock compensation issued for services during the three months ended March 31, 2024, were valued on the date of issuance. The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based stock compensation issued in the three months ended March 31, 2024: SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION 1/2/24 1/8/24 3/28/24 Risk-free interest rate 3.93 % 4.01 % 4.20 % Expected life 5 5 5 Expected dividends 0 % 0 % 0 % Expected volatility 91.92 % 92.01 % 89.73 % BIOF common stock fair value $ 0.083 $ 0.095 $ 0.105 Research and Development The Company expenses all research and development costs as incurred. For the three months ended March 31, 2024, and March 31, 2023, the amounts charged to research and development expenses were $ 607,635 684,562 Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide it with a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to its own stock as defined in ASC 815-40 (“Contracts in Entity’s Own Equity”). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. Net Income (Loss) per Common Share Basic Net income (loss) per share amounts have been calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted loss per share has been calculated using the weighted-average number of common shares plus the potentially dilutive effect of securities such as common stock that potentially could be issued upon the conversion of convertible notes or upon the exercise of outstanding options and warrants. The computation of potential common shares has been performed using the treasury stock method. Due to net losses, all potential dilutive securities are antidilutive for all periods presented. When net loss is reported, diluted and basic net loss per share amounts are the same as the impact of potential common shares is antidilutive. Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that may have an impact on the Company’s accounting and reporting. The Company believes that such recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations, and cash flows when implemented.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE 4 – PROPERTY AND EQUIPMENT SCHEDULE OF PROPERTY AND EQUIPMENT PROPERTY AND EQUIPMENT Life March 31, 2024 December 31, 2023 Building and Improvements 15 $ 9,370 $ 9,370 Machinery and Equipment 10 795,606 795,606 Furniture and Fixtures 5 13,596 13,596 Computer Equipment 3 11,825 11,825 Property and Equipment, gross $ 830,397 $ 830,397 Less Accumulated Depreciation (272,899 ) (243,089 ) Property and Equipment $ 557,498 $ 587,308 Total depreciation expense was $ 29,810

PATENTS

PATENTS	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
PATENTS	NOTE 5 – PATENTS The Company has been granted one patent on its technology and one continuation patent, has filed for three others that are pending, and has also applied for international patents. The Company has capitalized the legal and filing fees in the amount of $ 275,611

DEBT

DEBT	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
DEBT	NOTE 6 – DEBT Notes Payable – Related Parties In Q1 2024, the Company issued convertible notes to board member Chris Kneppers totaling $ 60,000 The Notes bear no interest and are convertible at the option of the lender into common shares of the Company at 8 cents per share, plus a warrant with a strike price of 10 cents per share and a 5 750,000 In 2023, the Company entered into long-term convertible notes with board member Chris Kneppers, with principal balances of $ 110,000 that are to be repaid when the Company receives $5 million in equity investment. The Notes carry a 10 % interest per annum. The Notes are convertible, at the option of the lender, into common shares of the Company at 15 cents per share, plus a warrant with a strike price of 25 cents per share and a 5 -year expiration, for a total of 733,333 shares and warrants. On November 11, 2023, and also on July 7, 2023, the Company entered into two long-term convertible notes with board member Edmund Burke, with a total principal balance of $ 15,000 25,000 they accrued warrants, with a strike price of 15 cents and an expiration of 5 years, at the rate of 50,000 and 30,000 respectively every 12 months instead of interest, with a minimum of 80,000 warrants. 0.13 307,692 In June 2023, the Company entered into a short-term convertible note with board member Chris Kneppers, with a principal balance of $ 100,000 0.13 769,231 In April 2023, the Company entered into a long-term convertible note with board member Edmund Burke, with a principal balance of $ 150,000 accrued warrants, with a strike price of 15 cents and an expiration of 5 0.13 1,153,846 In January 2023, the Company entered into a short-term convertible note with board member Chris Kneppers, with a principal balance of $ 250,000 0.13 1,923,077 Legacy Notes Payable – Related Party On May 31, 2019, the Company entered into an agreement with Chris and Pamela Jemapete such that its debt of $ 100,630 On May 20, 2019, the Company entered into an agreement with Steven Sadaka such that the $ 100,000 Between November 30, 2018 and December 14, 2018, the Company entered into agreements to renegotiate various debts owed to founders and related parties. These agreements were subject to the bankruptcy Court’s plan confirmation. The Plan, which was confirmed by the Court on September 18, 2019, indicated that the debt to Mark Koch shall be $ 240,990 579,942 1.5 Notes Payable – Other In Q1 2024, the Company issued convertible notes to 4 different individuals totaling $ 200,000 These notes carry no interest and may be prepaid at anytime, but are convertible, at the option of the lender, into common shares of the Company at 8 cents per shares plus a warrant with a strike price of 10 cents per share and a 5 2,500,000 In December 2023, the Company issued a convertible note to one individual for $ 50,000 This note carries no interest and may be prepaid at anytime, but are convertible, at the option of the lender, into common shares of the Company at 8 cents per shares plus a warrant with a strike price of 10 cents per share and a 5 625,000 Legacy Notes Payable – Other On March 19, 2019, the Company entered into an agreement with Lucas Hoppel, such that its combined debt on two notes shall be reduced to $ 100,000 5 On March 27, 2019, the Company entered into an agreement with another creditor, such that its debt will be reduced from $ 32,000 20,000 On November 30, 2018, the Company entered into an agreement with a third party such that its debt will be reduced to $ 96,570 50 A summary of all debts indicated in the Notes above is as follows: SCHEDULE OF NOTES PAYABLE Notes Payable March 31, 2024 December 31, 2023 Short Term Convertible Note – Related Party $ 370,000 $ 350,000 Short Term Convertible Notes — Other 200,000 0 Long Term Convertible Notes – Related Party 40,000 0 Long Term Convertible Notes -- Other 50,000 50,000 Long Term Convertible Notes Payable after equity investment – Related Party 300,000 300,000 Long Term Notes Payable from future revenue — Related Party 200,630 200,630 Long Term Notes Payable from future revenue — Other 120,000 120,000 Long-Term Notes Payable expiring on September 18, 2024 — Related Party 2,320,932 2,320,932 Long Term Notes Payable expiring on September 18, 2024 — Other 96,570 96,570 TOTAL NOTES $ 3,698,132 $ 3,438,132 Only $ 100,000 of the $ 3,698,132 payable as of March 31, 2024, is payable in cash at a specific point in time. $ 300,000 is due only after a significant capital investment. $ 320,630 is due out of future revenue with no specific due date. $ 2,417,502 1,230,630 860,630 370,000

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 7 – STOCKHOLDERS’ EQUITY The total number of shares of capital stock, which the Company has authority to issue, is 1,010 1 0.001 10 0.001 302,803,463 no Holders of shares of Common stock shall be entitled to cast one vote for each share held For the three months ended March 31, 2024, the Company issued an aggregate of 52,500 4,200 For the three months ended March 31, 2024, 87,500 5,494 For the three months ended March 31, 2024, 0 For the three months ended March 31, 2024, 133,333 23,945,143 For the three months ended March 31, 2024, 1,875,000 251,290 27,958 6,175,000 29,955,000 31,600,000 At March 31, 2024, there was $ 960,000 8,762,179 4,608,333

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 8 - COMMITMENTS AND CONTINGENCIES Litigation The Company is subject, from time to time, to litigation, claims and suits arising in the ordinary course of business. The Company is not in any litigation at this time. Leases The Company currently leases office and laboratory space in Palm Beach Gardens, FL, that is classified as operating lease right-of-use (“ROU”) assets and operating lease liabilities in the Company’s consolidated balance sheet. Rent expense for the three months ending March 31, 2024, and 2023, were $ 25,977 24,327 60,637

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 9 – RELATED PARTY TRANSACTIONS Related Party Transactions Related Party transactions with the Company are as follows: 1) Short-term notes payable, convertible notes, and legacy liabilities issued to related parties are described in NOTE 6. 2) A board resolution was passed on February 13, 2020, that pledged the patents and pending patents to secure the back pay claims of Ben Slager, CEO, Anthony Santelli, CFO, and Charles Sills, Director. This was done to ensure the continued involvement of management to build the Company while they receive less than full salaries. 3) During the three month period ended March 31, 2024, the board approved an increase in salaries to two officers of the Company retroactive to August 1, 2023, in light of the fact that they are again accruing unpaid salaries. CEO Ben Slager is to receive $ 525,000 325,000

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 – SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date the financial statements were issued. Based on this evaluation, the Company has identified the following subsequent events: From April 1, 2024, to the date of this filing, the Company issued 140,000 warrants for services and cancelled 350,000 warrants. From April 1, 2024, to the date of this filing, the Company issued convertible notes to related parties for $ 80,000 50,000

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The condensed consolidated financial statements are prepared in accordance with Operating results for the three months ended March 31, 2024, may not be indicative of full year 2024 results. In management’s opinion, the accompanying condensed consolidated financial statements contain all adjustments necessary for a fair statement of our financial position as of March 31, 2024, and our results of operations, changes in stockholders’ deficit and cash flows for the three months ended March 31, 2024 and 2023.
Stock Compensation	Stock Compensation The Company recognizes the cost of all share-based payments under the relevant authoritative accounting guidance. Share-based payments include any remuneration paid by the Company in shares of the Company’s common stock or financial instruments that grant the recipient the right to acquire shares of the Company’s common stock. For share-based payments to employees, which consist only of awards made under the stock option plan described below, the Company accounts for the payments in accordance with the provisions of ASC Topic 718, “Stock Compensation”. Share-based payments to consultants, service providers and other non-employees are accounted for in accordance with ASC Topic 718, or other applicable authoritative guidance.
Stock-based Compensation Valuation Methodology	Stock-based Compensation Valuation Methodology Stock-based compensation resulting from the issuance of common stock is calculated by reference to the valuation of the stock on the date of issuance, the expense being recognized as the compensation is earned. Stock-based compensation expenses related to employee options and warrants granted to non-employees are recognized as the stock options and warrants are earned. The fair value of the stock options or warrants granted is estimated at the grant date, using the Black-Scholes option-pricing model, and the expense is recognized on a straight-line basis over the shorter of the period over which services are to be received or the life of the option or warrant. The grant date fair value of employee share options and similar instruments is estimated using the Black-Scholes option-pricing model on the basis of the fair value of the underlying common stock on the measurement date, adjusted for the unique characteristics of those equity instruments, using the assumptions noted in the table below. The fair value of the common stock is determined by the then-prevailing closing market price. Expected volatility was based on the historical volatility of the Company’s closing day market price per share. The expected term of options and warrants was based upon the life of the option, and the risk-free rate used was based on the U.S. Treasury Daily Yield Curve Rate. The stock compensation issued for services during the three months ended March 31, 2024, were valued on the date of issuance. The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based stock compensation issued in the three months ended March 31, 2024: SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION 1/2/24 1/8/24 3/28/24 Risk-free interest rate 3.93 % 4.01 % 4.20 % Expected life 5 5 5 Expected dividends 0 % 0 % 0 % Expected volatility 91.92 % 92.01 % 89.73 % BIOF common stock fair value $ 0.083 $ 0.095 $ 0.105
Research and Development	Research and Development The Company expenses all research and development costs as incurred. For the three months ended March 31, 2024, and March 31, 2023, the amounts charged to research and development expenses were $ 607,635 684,562
Common Stock Purchase Warrants and Other Derivative Financial Instruments	Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide it with a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to its own stock as defined in ASC 815-40 (“Contracts in Entity’s Own Equity”). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
Net Income (Loss) per Common Share	Net Income (Loss) per Common Share Basic Net income (loss) per share amounts have been calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted loss per share has been calculated using the weighted-average number of common shares plus the potentially dilutive effect of securities such as common stock that potentially could be issued upon the conversion of convertible notes or upon the exercise of outstanding options and warrants. The computation of potential common shares has been performed using the treasury stock method. Due to net losses, all potential dilutive securities are antidilutive for all periods presented. When net loss is reported, diluted and basic net loss per share amounts are the same as the impact of potential common shares is antidilutive.
Recent Accounting Pronouncements	Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that may have an impact on the Company’s accounting and reporting. The Company believes that such recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations, and cash flows when implemented.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION	The stock compensation issued for services during the three months ended March 31, 2024, were valued on the date of issuance. The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based stock compensation issued in the three months ended March 31, 2024: SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION 1/2/24 1/8/24 3/28/24 Risk-free interest rate 3.93 % 4.01 % 4.20 % Expected life 5 5 5 Expected dividends 0 % 0 % 0 % Expected volatility 91.92 % 92.01 % 89.73 % BIOF common stock fair value $ 0.083 $ 0.095 $ 0.105

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY AND EQUIPMENT	SCHEDULE OF PROPERTY AND EQUIPMENT PROPERTY AND EQUIPMENT Life March 31, 2024 December 31, 2023 Building and Improvements 15 $ 9,370 $ 9,370 Machinery and Equipment 10 795,606 795,606 Furniture and Fixtures 5 13,596 13,596 Computer Equipment 3 11,825 11,825 Property and Equipment, gross $ 830,397 $ 830,397 Less Accumulated Depreciation (272,899 ) (243,089 ) Property and Equipment $ 557,498 $ 587,308

DEBT (Tables)

DEBT (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
SCHEDULE OF NOTES PAYABLE	A summary of all debts indicated in the Notes above is as follows: SCHEDULE OF NOTES PAYABLE Notes Payable March 31, 2024 December 31, 2023 Short Term Convertible Note – Related Party $ 370,000 $ 350,000 Short Term Convertible Notes — Other 200,000 0 Long Term Convertible Notes – Related Party 40,000 0 Long Term Convertible Notes -- Other 50,000 50,000 Long Term Convertible Notes Payable after equity investment – Related Party 300,000 300,000 Long Term Notes Payable from future revenue — Related Party 200,630 200,630 Long Term Notes Payable from future revenue — Other 120,000 120,000 Long-Term Notes Payable expiring on September 18, 2024 — Related Party 2,320,932 2,320,932 Long Term Notes Payable expiring on September 18, 2024 — Other 96,570 96,570 TOTAL NOTES $ 3,698,132 $ 3,438,132

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated losses	$ 56,783,652	$ 55,836,780

SCHEDULE OF BLACK-SCHOLES OPTIO

SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION (Details) - Warrant [Member]	3 Months Ended
	Mar. 31, 2024 $ / shares
Issuance Date 01/02/24 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	3.93%
Expected life	5 years
Expected dividends	0%
Expected volatility	91.92%
BIOF common stock fair value	$ 0.083
Issuance Date 01/08/2024 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	4.01%
Expected life	5 years
Expected dividends	0%
Expected volatility	92.01%
BIOF common stock fair value	$ 0.095
Issuance Date 03/28/2024 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	4.20%
Expected life	5 years
Expected dividends	0%
Expected volatility	89.73%
BIOF common stock fair value	$ 0.105

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Research and development expenses	$ 607,635	$ 684,562
Research and Development Expense [Member]
Research and development expenses	$ 607,635	$ 684,562

SCHEDULE OF PROPERTY AND EQUIPM

SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 830,397	$ 830,397
Less Accumulated Depreciation	(272,899)	(243,089)
Property and Equipment	557,498	587,308
Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 9,370	9,370
Estimated useful lives	15 years
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 795,606	795,606
Estimated useful lives	10 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 13,596	13,596
Estimated useful lives	5 years
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 11,825	$ 11,825
Estimated useful lives	3 years

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details Narrative)	3 Months Ended
	Mar. 31, 2024 USD ($)
Property, Plant and Equipment [Abstract]
Depreciation	$ 29,810

PATENTS (Details Narrative)

PATENTS (Details Narrative) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-lived patents	$ 275,611	$ 254,786

SCHEDULE OF NOTES PAYABLE (Deta

SCHEDULE OF NOTES PAYABLE (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
Short Term Convertible Note – Related Party	$ 370,000	$ 350,000
Short Term Convertible Notes — Other	200,000	0
Long Term Convertible Notes – Related Party	40,000	0
Long Term Convertible Notes -- Other	50,000	50,000
Long Term Convertible Notes Payable after equity investment – Related Party	300,000	300,000
Long Term Notes Payable from future revenue — Related Party	200,630	200,630
Long Term Notes Payable from future revenue — Other	120,000	120,000
Long-Term Notes Payable expiring on September 18, 2024 — Related Party	2,320,932	2,320,932
Long Term Notes Payable expiring on September 18, 2024 — Other	96,570	96,570
TOTAL NOTES	$ 3,698,132	$ 3,438,132

DEBT (Details Narrative)

DEBT (Details Narrative) - USD ($)

1 Months Ended

3 Months Ended

Nov. 11, 2023

Jul. 07, 2023

Jun. 30, 2023

May 20, 2019

Mar. 19, 2019

Nov. 30, 2018

Dec. 31, 2023

Jun. 30, 2023

Apr. 30, 2023

Jan. 31, 2023

Mar. 31, 2024

Dec. 31, 2024

Dec. 13, 2023

Sep. 18, 2019

May 31, 2019

Mar. 27, 2019

Mar. 26, 2019

Short-Term Debt [Line Items]

Conversion of convertible securities, shares

8,762,179

Notes payable

$ 3,438,132

$ 3,698,132

Notes payable, noncurrent

$ 20,000

$ 32,000

Due out of long term at specific point

100,000

Debt Instrument, Convertible, Carrying Amount of Equity Component

300,000

Due out of long term future revenue

320,630

Notes payable amount to be discharged

2,417,502

Other Liabilities

1,230,630

Notes Payable Other [Member]

Short-Term Debt [Line Items]

Convertible notes

$ 50,000

$ 200,000

Warrant [Member] | Notes Payable Other [Member]

Short-Term Debt [Line Items]

Conversion of convertible securities, shares

625,000

2,500,000

Warrant [Member] | Convertible Debt One [Member]

Short-Term Debt [Line Items]

Debt instrument, term

5 years

5 years

Notes Payable Other [Member]

Short-Term Debt [Line Items]

Debt instrument, description

This note carries no interest and may be prepaid at anytime, but are convertible, at the option of the lender, into common shares of the Company at 8 cents per shares plus a warrant with a strike price of 10 cents per share and a 5-year expiration for a total of 625,000 shares and warrants

These notes carry no interest and may be prepaid at anytime, but are convertible, at the option of the lender, into common shares of the Company at 8 cents per shares plus a warrant with a strike price of 10 cents per share and a 5-year expiration for a total of 2,500,000 shares and warrants

Chris Kneppers [Member]

Short-Term Debt [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

10%

10%

Chris Kneppers [Member] | Convertible Debt One [Member]

Short-Term Debt [Line Items]

Principal balance

$ 110,000

Chris Kneppers [Member] | Convertible Debt [Member]

Short-Term Debt [Line Items]

Principal balance

$ 250,000

Chris Kneppers [Member] | Warrant [Member] | Convertible Debt One [Member]

Short-Term Debt [Line Items]

Debt instrument, term

5 years

Conversion of convertible securities, shares

733,333

750,000

Chris Kneppers [Member] | Common Stock [Member] | Convertible Debt [Member]

Short-Term Debt [Line Items]

Conversion of convertible securities, shares

1,923,077

Convertible, conversion price per share

$ 0.13

Chris Kneppers [Member] | Convertible Debt One [Member]

Short-Term Debt [Line Items]

Debt instrument, description

The Notes are convertible, at the option of the lender, into common shares of the Company at 15 cents per share, plus a warrant with a strike price of 25 cents per share and a

The Notes bear no interest and are convertible at the option of the lender into common shares of the Company at 8 cents per share, plus a warrant with a strike price of 10 cents per share and a 5-year expiration for a total of 750,000 shares and warrants

Debt instrument, term

5 years

Chris Kneppers [Member] | Convertible Debt Two [Member]

Short-Term Debt [Line Items]

Principal balance

$ 100,000

$ 100,000

Chris Kneppers [Member] | Convertible Debt Two [Member] | Common Stock [Member]

Short-Term Debt [Line Items]

Conversion of convertible securities, shares

769,231

Convertible, conversion price per share

$ 0.13

$ 0.13

Chris Kneppers [Member] | Forecast [Member]

Short-Term Debt [Line Items]

Convertible notes

$ 60,000

Edmund Burke [Member] | Convertible Debt [Member]

Short-Term Debt [Line Items]

Debt instrument, term

5 years

Principal balance

$ 15,000

$ 25,000

$ 150,000

Warrant, reason for issuance, description

they accrued warrants, with a strike price of 15 cents and an expiration of 5 years, at the rate of 50,000 and 30,000 respectively every 12 months instead of interest, with a minimum of 80,000 warrants.

they accrued warrants, with a strike price of 15 cents and an expiration of 5 years, at the rate of 50,000 and 30,000 respectively every 12 months instead of interest, with a minimum of 80,000 warrants.

accrued warrants, with a strike price of 15 cents and an expiration of 5 years, at the rate of 100,000 every 6 months instead of interest. It may convert into common stock at $0.13/share at the option of the holder for a total of 1,153,846 shares.

Edmund Burke [Member] | Common Stock [Member] | Convertible Debt [Member]

Short-Term Debt [Line Items]

Conversion of convertible securities, shares

307,692

307,692

1,153,846

Convertible, conversion price per share

$ 0.13

$ 0.13

$ 0.13

Pamela Jemapete [Member] | Loans Payable [Member]

Short-Term Debt [Line Items]

Principal balance

$ 100,630

Christopher Jemapete [Member] | Loans Payable [Member]

Short-Term Debt [Line Items]

Amount to be paid out of future gross revenues

$ 100,000

Mark Koch [Member]

Short-Term Debt [Line Items]

Notes payable

$ 240,990

Animated Family Films [Member]

Short-Term Debt [Line Items]

Notes payable

579,942

Steven Dunkle [Member]

Short-Term Debt [Line Items]

Notes payable

1,500,000

CTWC [Member]

Short-Term Debt [Line Items]

Notes payable

1,500,000

Wellington Asset Holdings [Member]

Short-Term Debt [Line Items]

Notes payable

$ 1,500,000

Lucas Hoppel [Member]

Short-Term Debt [Line Items]

Interest reduced

$ 100,000

Percentage of future gross revenues

5%

Third Party [Member]

Short-Term Debt [Line Items]

Debt

$ 96,570

Percenatge of future net profits

50%

Related Party [Member]

Short-Term Debt [Line Items]

Notes payable, noncurrent

$ 2,521,562

$ 2,521,562

Other Liabilities

860,630

Other Related Party [Member]

Short-Term Debt [Line Items]

Other Liabilities

$ 370,000

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)		3 Months Ended
	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Capital units, authorized	1,010,000,000	1,010,000,000
Common stock, shares authorized	1,000,000,000	1,000,000,000		1,000,000,000
Common stock, par value	$ 0.001	$ 0.001		$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000		10,000,000
Preferred stock, par value	$ 0.001	$ 0.001		$ 0.001
Common stock, shares issued	302,803,463	302,803,463		302,750,963
Common stock, shares outstanding	302,803,463	302,803,463		302,750,963
Preferred stock, shares issued	0	0		0
Preferred stock, shares outstanding	0	0		0
Description of voting rights of common stock		Holders of shares of Common stock shall be entitled to cast one vote for each share held
Number of shares issued for services, shares		52,500
Number of shares issued for services, value		$ 4,200	$ 24,000
Issuance of common stock and warrants for cash through PPM, shares		0
Warrants exercised, shares	133,333	133,333
Warrants exercised share, shares	23,945,143	23,945,143
Number of shares vested	29,955,000	1,875,000	2,385,000
Options issued and vested value		$ 251,290
Stock based compensation		$ 27,958
Stock based compensation exercise price of vested options, shares	6,175,000	6,175,000
Number of shares unvested	31,600,000	31,600,000
Convertible note		$ 960,000
Convertible note convertion of shares		8,762,179
Convertible note conversion of warrants		4,608,333
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued for services, shares		87,500
Number of shares issued for services, value		$ 5,494

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$ 25,977	$ 24,327
Future minimum lease payments	$ 60,637

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative)	3 Months Ended
	Mar. 31, 2024 USD ($)
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Salary received	$ 525,000
Chief Financial Officer [Member]
Related Party Transaction [Line Items]
Salary received	$ 325,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	May 05, 2024	Mar. 31, 2024
Subsequent Event [Line Items]
Warrants issued for service		87,500
Subsequent Event [Member] | Related Party [Member]
Subsequent Event [Line Items]
Convertible note	$ 80,000
Subsequent Event [Member] | Nonrelated Party [Member]
Subsequent Event [Line Items]
Convertible note	$ 50,000
Warrant [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Warrants issued for service	140,000
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited	350,000